At ROVI we don't believe in borders
Since its foundation, ROVI has had a clearly international outlook. Currently we are present in over 100 countries, as a result of implementing a strategy that began in 1998 and has been oriented towards growth and internationalisation of our low-molecular-weight heparins (LMWH).
Reaching more countries and more people
![ISM ISM](/sites/default/files/morecountryboxleftimg.png)
ROVI markets different drugs all over the world. Bemiparin is one of its main drivers and has the most extensive international track record, present in more than 60 countries.
![ISM ISM](/sites/default/files/morecountryboxrightimg.png)
Our enoxaparin biosimilar, which is now present in 38 countries, is boosting ROVI's international presence.